These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 28705644)

  • 81. Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications.
    Vela D; Vela-Gaxha Z
    Exp Mol Med; 2018 Feb; 50(2):e436. PubMed ID: 29391539
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Discovery of DS79182026: A potent orally active hepcidin production inhibitor.
    Fukuda T; Goto R; Kiho T; Ueda K; Muramatsu S; Hashimoto M; Aki A; Watanabe K; Tanaka N
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3716-3722. PubMed ID: 28705644
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Hepcidin and IL-1β.
    Kanamori Y; Murakami M; Sugiyama M; Hashimoto O; Matsui T; Funaba M
    Vitam Horm; 2019; 110():143-156. PubMed ID: 30798809
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Beyond anemia: hepcidin, monocytes and inflammation.
    Zhang X; Rovin BH
    Biol Chem; 2013 Feb; 394(2):231-8. PubMed ID: 23314535
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Hepcidin: Homeostasis and Diseases Related to Iron Metabolism.
    Reichert CO; da Cunha J; Levy D; Maselli LMF; Bydlowski SP; Spada C
    Acta Haematol; 2017; 137(4):220-236. PubMed ID: 28514781
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The iron-regulatory hormone hepcidin: a possible therapeutic target?
    Rochette L; Gudjoncik A; Guenancia C; Zeller M; Cottin Y; Vergely C
    Pharmacol Ther; 2015 Feb; 146():35-52. PubMed ID: 25205158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 5.